Meloxicam inhibits the growth of colorectal cancer cells

Carcinogenesis

Volumn 19, Issue 12, 1998, Pages 2195-2199

  Goldman, Angela P ^a   Williams, Christopher S ^a   Sheng, Hongmiao ^a   Lamps, Laura W ^a   Williams, Vanessa P ^a   Pairet, Michel ^b   D morrow, Jason ^a   DuBois, Raymond N ^a,c,d  

^a VANDERBILT UNIVERSITY   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL LINE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; COLLAGEN; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG COMBINATIONS; HUMANS; ISOENZYMES; LAMININ; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEOGLYCANS; THIAZINES; THIAZOLES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032405901     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.12.2195     Document Type: Article

References (25)

1. Thun,M.J., Namboodiri,M.M., Calle,E.E., Flanders,W.D. and Heath,C.W.J. (1993) Aspirin use and risk of fatal cancer. Cancer Res., 53, 1322-1327.
2. Thun,M.J., Namboodiri,M.M. and Heath,C.W.J. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596.
3. Giovannucci,E., Egan,K.M., Hunter,D.J., Stampfer,M.J., Colditz,G.A., Willett,W.C. and Speizer,F.E. (1995) Aspirin and the risk of colorectal cancer in women. N. Eng. J. Med., 333, 609-614.
4. Giovannucci,E., Rimm,E.B., Stampfer,M.J., Colditz,G.A., Ascherio,A. and Willett,W.C. (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121, 241-246.
5. DuBois,R.N. and Smalley,W.E. (1996) Cyclooxygenase, NSAIDs and colorectal cancer. J. Gastroenterol., 31, 898-906.
6. Smalley,W. and DuBois,R.N. (1997) Colorectal cancer and non-steroidal anti-inflammatory drugs. Adv. Pharmacol., 39, 1-20.
7. Scheiman,J.M. (1996) NSAIDs, gastrointestinal injury and cytoprotection. Gastroenterol. Clin. N. Am., 25, 279-298.
8. Wong,E., Bayly,C., Waterman,H.L., Riendeau,D. and Mancin,J.A. (1997) Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513, Arg and Ile523, Val mutation. J. Biol. Chem., 272, 9280-9286.
9. Pairet,M., Van Ryn,J., Schierok,H., Mauz,A., Trummlitz,G. and Engelhardt,G. (1998) Differential inhibition of Cyclooxygenase-1 and -2 by meloxicam and its 4′-isomer. Inflamm. Res., 47, 270-276.
10. Sheng,H., Shao,J., Kirkland,S.C., Isakson,P., Coffey,R., Morrow,J., Beauchamp,R.D. and DuBois,R.N. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99, 2254-2259.
11. 716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell, 87, 803-809.
12. Reddy,B.S., Rao,C.V. and Seibert,K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569.
13. Kawamori,T., Rao,C.V., Seibert,K. and Reddy,B.S. (1998) Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412.
14. Shiff,S.J. and Rigas,B. (1997) Non-steroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology, 113, 1992-1998.
15. Piazza,G.A., Rahm,A.L., Krutzsch,M., et al. (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55, 3110-3116.
16. DuBois,R.N., Awad,J., Morrow,J., Roberts,L.J. and Bishop,P.R. (1994) Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest., 93, 493-498.
17. Coffey,R J., Hawkey,C.J., Damstrup,L., Graves-Deal,R., Daniel,V.C., Dempsey,P.J., DuBois,R.N., Jetton,T. and Morrow,J. (1997) EGF receptor activation induces nuclear targeting of COX-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc. Natl Acad. Sci. USA, 94, 657-662.
18. Rosenberg,L., Palmer,J., Zauber,A., Washauer,M., Stolley,P. and Shapiro,S. (1991) A hypothesis: non-steroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl Cancer Inst., 83, 355-358.
19. Suh,O., Mettlin,C. and Petrelli,N.J. (1993) Aspirin use, cancer and polyps of the large bowel. Cancer, 72, 1171-1177.
20. Logan,R.E, Little,J., Hawkin,P.G. and Hardcastle,J.D. (1993) Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br. Med. J., 307, 285-289.
21. Peleg,II., Maibach,H.T., Brown,S.H. and Wilcox,C.M. (1994) Aspirin and non-steroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Intern. Med., 154, 394-399.
22. Muscat,J.E., Stellman,S.D. and Wynder,E.L. (1994) Non-steroidal anti-inflammatory drugs and colorectal cancer. Cancer, 74, 1847-1854.
23. Davis,A.E. and Patterson,F. (1994) Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model. Austr. N.Z. J. Med., 24, 301-303.
24. Wargovich,M.J., Chen,C.D., Harris,C., Yang,E. and Velasco,M. (1995) Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int. J. Cancer, 60, 515-519.
25. Reddy,B.S., Rao,C.V. and Seibert,K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569.